CLINICAL CORNER: Medtronic Tests Evolut R In Real World; Rheonix And MDxHealth Tout IVD Trial Data
This article was originally published in Clinica
Clinica’s Clinical Corner provides an update on the latest R&D news and developments in ongoing clinical trials of early-, late-stage and approved medical devices.
You may also be interested in...
The company’s leadership discussed its recent investments in robotic surgery technology during Johnson & Johnson’s 2019 fourth-quarter earnings call on 22 January. The company will provide more information on its robotic surgery platforms at its investors meeting in May in New York.
Three-month results from a 94-patient randomized trial of Medtronic’s Intellis spinal cord stimulation system showed superior back-pain relief with the differential target multiplexed waveform compared to conventional spinal cord stimulation.
The US FDA approved fewer novel devices in 2019 than in 2018, despite a slight increase in original PMA approvals. De novo clearances were down significantly after four straight years of increases, while panel-track PMA supplements and 510(k) clearances also declined from the 2018 totals.